https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Economic burden of irritable bowel syndrome in China https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29440 Wed 11 Apr 2018 14:37:54 AEST ]]> Assessment of the quality of pharmacoeconomic evaluation literature in China https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:32473 Wed 06 Jun 2018 14:11:27 AEST ]]> "What is important during the selection of Traditional Chinese Medicine (TCM) in a health care reimbursement or insurance system?" Critical issues of assessment from the perspective of TCM practitioners https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:18482 Sat 24 Mar 2018 07:59:49 AEDT ]]> Analysis of the utilization status of essential medicines in Beijing’s community health institutions https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:30631 Sat 24 Mar 2018 07:39:04 AEDT ]]> Evaluation of impact on health-related quality of life and cost effectiveness of traditional chinese medicine: a systematic review of randomized clinical trials https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:23515 Sat 24 Mar 2018 07:17:17 AEDT ]]> Is there a difference between EQ-5D and SF-6D in the clinical setting? a comparative study on the quality of life measured by AIMS2-SF, EQ-5D and SF-6D scales for osteoarthritis patients https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36023 Fri 24 Jan 2020 16:36:10 AEDT ]]>